{
  "fullName": "K. Rajender Reddy",
  "slug": "k-rajender-reddy",
  "title": "MD",
  "specialty": "Hepatology",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 28,
  "hIndex": 117,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Etela Rajender is an Indian politician from Telangana serving as the Member of Parliament from Malkajgiri Lok Sabha constituency. He previously served as the first Finance Minister of Telangana from 2014 to 2018 and as the Health Minister of Telangana from 2019 to 2021. He is a member of Bharatiya Janata Party since 2021.",
  "aiSummary": "K. Rajender Reddy is a hepatology specialist with an H-index of 117 at Univ. of Pennsylvania (Member). Has been published in New England Journal of Medicine, The Lancet, The Lancet Infectious Diseases. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Univ. of Pennsylvania"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Univ. of Pennsylvania",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Hepatology"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection",
      "journal": "New England Journal of Medicine",
      "year": 2002,
      "citationCount": 6389,
      "doi": "10.1056/nejmoa020047",
      "sourceUrl": "https://doi.org/10.1056/nejmoa020047",
      "verified": true
    },
    {
      "title": "Boceprevir for Untreated Chronic HCV Genotype 1 Infection",
      "journal": "New England Journal of Medicine",
      "year": 2011,
      "citationCount": 2495,
      "doi": "10.1056/nejmoa1010494",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1010494",
      "verified": true
    },
    {
      "title": "Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection",
      "journal": "New England Journal of Medicine",
      "year": 2011,
      "citationCount": 2372,
      "doi": "10.1056/nejmoa1012912",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1012912",
      "verified": true
    },
    {
      "title": "Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection",
      "journal": "The American Journal of Gastroenterology",
      "year": 2002,
      "citationCount": 2057,
      "doi": "10.1111/j.1572-0241.2002.06038.x",
      "sourceUrl": "https://doi.org/10.1111/j.1572-0241.2002.06038.x",
      "verified": true
    },
    {
      "title": "Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection",
      "journal": "New England Journal of Medicine",
      "year": 2013,
      "citationCount": 1776,
      "doi": "10.1056/nejmoa1214853",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1214853",
      "verified": true
    },
    {
      "title": "Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection",
      "journal": "New England Journal of Medicine",
      "year": 2014,
      "citationCount": 1297,
      "doi": "10.1056/nejmoa1316366",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1316366",
      "verified": true
    },
    {
      "title": "Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection",
      "journal": "New England Journal of Medicine",
      "year": 2014,
      "citationCount": 1188,
      "doi": "10.1056/nejmoa1306218",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1306218",
      "verified": true
    },
    {
      "title": "Diagnosis and Treatment of Hepatocellular Carcinoma",
      "journal": "Gastroenterology",
      "year": 2008,
      "citationCount": 1125,
      "doi": "10.1053/j.gastro.2008.02.090",
      "sourceUrl": "https://doi.org/10.1053/j.gastro.2008.02.090",
      "verified": true
    },
    {
      "title": "Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis",
      "journal": "New England Journal of Medicine",
      "year": 2014,
      "citationCount": 1118,
      "doi": "10.1056/nejmoa1402355",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1402355",
      "verified": true
    },
    {
      "title": "Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis",
      "journal": "New England Journal of Medicine",
      "year": 2000,
      "citationCount": 885,
      "doi": "10.1056/nejm200012073432302",
      "sourceUrl": "https://doi.org/10.1056/nejm200012073432302",
      "verified": true
    },
    {
      "title": "American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy",
      "journal": "Gastroenterology",
      "year": 2014,
      "citationCount": 845,
      "doi": "10.1053/j.gastro.2014.10.039",
      "sourceUrl": "https://doi.org/10.1053/j.gastro.2014.10.039",
      "verified": true
    },
    {
      "title": "Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease",
      "journal": "Gastroenterology",
      "year": 2015,
      "citationCount": 795,
      "doi": "10.1053/j.gastro.2015.05.010",
      "sourceUrl": "https://doi.org/10.1053/j.gastro.2015.05.010",
      "verified": true
    },
    {
      "title": "Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis",
      "journal": "New England Journal of Medicine",
      "year": 2015,
      "citationCount": 794,
      "doi": "10.1056/nejmoa1512614",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1512614",
      "verified": true
    },
    {
      "title": "α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma",
      "journal": "Gastroenterology",
      "year": 2009,
      "citationCount": 746,
      "doi": "10.1053/j.gastro.2009.04.005",
      "sourceUrl": "https://doi.org/10.1053/j.gastro.2009.04.005",
      "verified": true
    },
    {
      "title": "Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection",
      "journal": "Clinical Infectious Diseases",
      "year": 2018,
      "citationCount": 718,
      "doi": "10.1093/cid/ciy585",
      "sourceUrl": "https://doi.org/10.1093/cid/ciy585",
      "verified": true
    },
    {
      "title": "ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV",
      "journal": "New England Journal of Medicine",
      "year": 2014,
      "citationCount": 690,
      "doi": "10.1056/nejmoa1402338",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1402338",
      "verified": true
    },
    {
      "title": "Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection",
      "journal": "New England Journal of Medicine",
      "year": 2017,
      "citationCount": 557,
      "doi": "10.1056/nejmoa1613512",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1613512",
      "verified": true
    },
    {
      "title": "Survival in Infection-Related Acute-on-Chronic Liver Failure Is Defined by Extrahepatic Organ Failures",
      "journal": "Hepatology",
      "year": 2014,
      "citationCount": 557,
      "doi": "10.1002/hep.27077",
      "sourceUrl": "https://doi.org/10.1002/hep.27077",
      "verified": true
    },
    {
      "title": "Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD)/ribavirin",
      "journal": "Journal of Hepatology",
      "year": 2005,
      "citationCount": 517,
      "doi": "10.1016/j.jhep.2005.04.009",
      "sourceUrl": "https://doi.org/10.1016/j.jhep.2005.04.009",
      "verified": true
    },
    {
      "title": "Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection",
      "journal": "Annals of Internal Medicine",
      "year": 2015,
      "citationCount": 514,
      "doi": "10.7326/m15-0785",
      "sourceUrl": "https://doi.org/10.7326/m15-0785",
      "verified": true
    },
    {
      "title": "Coagulation disorders and hemostasis in liver disease",
      "journal": "Hepatology",
      "year": 2006,
      "citationCount": 511,
      "doi": "10.1002/hep.21303",
      "sourceUrl": "https://doi.org/10.1002/hep.21303",
      "verified": true
    },
    {
      "title": "Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement",
      "journal": "Hepatology",
      "year": 2020,
      "citationCount": 474,
      "doi": "10.1002/hep.31281",
      "sourceUrl": "https://doi.org/10.1002/hep.31281",
      "verified": true
    },
    {
      "title": "ACG Clinical Guideline: The Diagnosis and Management of Focal Liver Lesions",
      "journal": "The American Journal of Gastroenterology",
      "year": 2014,
      "citationCount": 471,
      "doi": "10.1038/ajg.2014.213",
      "sourceUrl": "https://doi.org/10.1038/ajg.2014.213",
      "verified": true
    },
    {
      "title": "Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α-2a (40 kd)/ribavirin therapy",
      "journal": "Hepatology",
      "year": 2006,
      "citationCount": 469,
      "doi": "10.1002/hep.21159",
      "sourceUrl": "https://doi.org/10.1002/hep.21159",
      "verified": true
    },
    {
      "title": "Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation",
      "journal": "The Lancet",
      "year": 1997,
      "citationCount": 446,
      "doi": "10.1016/s0140-6736(96)02266-0",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(96)02266-0",
      "verified": true
    },
    {
      "title": "The North American Study for the Treatment of Refractory Ascites",
      "journal": "Gastroenterology",
      "year": 2003,
      "citationCount": 434,
      "doi": "10.1053/gast.2003.50088",
      "sourceUrl": "https://doi.org/10.1053/gast.2003.50088",
      "verified": true
    },
    {
      "title": "Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome",
      "journal": "New England Journal of Medicine",
      "year": 2021,
      "citationCount": 418,
      "doi": "10.1056/nejmoa2008290",
      "sourceUrl": "https://doi.org/10.1056/nejmoa2008290",
      "verified": true
    },
    {
      "title": "Second infections independently increase mortality in hospitalized patients With cirrhosis: the north american consortium for the study of end-stage liver disease (NACSELD) experience",
      "journal": "Hepatology",
      "year": 2012,
      "citationCount": 408,
      "doi": "10.1002/hep.25947",
      "sourceUrl": "https://doi.org/10.1002/hep.25947",
      "verified": true
    },
    {
      "title": "Hepatic Histological Findings in Suspected Drug-Induced Liver Injury: Systematic Evaluation and Clinical Associations",
      "journal": "Hepatology",
      "year": 2013,
      "citationCount": 403,
      "doi": "10.1002/hep.26709",
      "sourceUrl": "https://doi.org/10.1002/hep.26709",
      "verified": true
    },
    {
      "title": "Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network",
      "journal": "Hepatology",
      "year": 2014,
      "citationCount": 402,
      "doi": "10.1002/hep.27317",
      "sourceUrl": "https://doi.org/10.1002/hep.27317",
      "verified": true
    },
    {
      "title": "Immune Dysfunction and Infections in Patients With Cirrhosis",
      "journal": "Clinical Gastroenterology and Hepatology",
      "year": 2011,
      "citationCount": 381,
      "doi": "10.1016/j.cgh.2011.02.031",
      "sourceUrl": "https://doi.org/10.1016/j.cgh.2011.02.031",
      "verified": true
    },
    {
      "title": "Outcomes in Adults With Acute Liver Failure Between 1998 and 2013",
      "journal": "Annals of Internal Medicine",
      "year": 2016,
      "citationCount": 372,
      "doi": "10.7326/m15-2211",
      "sourceUrl": "https://doi.org/10.7326/m15-2211",
      "verified": true
    },
    {
      "title": "Efficacy and Safety of Pegylated (40–Kd) Interferon α–2A Compared With Interferon α–2A in Noncirrhotic Patients With Chronic Hepatitis C",
      "journal": "Hepatology",
      "year": 2001,
      "citationCount": 360,
      "doi": "10.1053/jhep.2001.21747",
      "sourceUrl": "https://doi.org/10.1053/jhep.2001.21747",
      "verified": true
    },
    {
      "title": "Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients",
      "journal": "New England Journal of Medicine",
      "year": 2017,
      "citationCount": 348,
      "doi": "10.1056/nejmc1705221",
      "sourceUrl": "https://doi.org/10.1056/nejmc1705221",
      "verified": true
    },
    {
      "title": "Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study",
      "journal": "Hepatology",
      "year": 2000,
      "citationCount": 336,
      "doi": "10.1002/hep.510310103",
      "sourceUrl": "https://doi.org/10.1002/hep.510310103",
      "verified": true
    },
    {
      "title": "ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury",
      "journal": "The American Journal of Gastroenterology",
      "year": 2021,
      "citationCount": 334,
      "doi": "10.14309/ajg.0000000000001259",
      "sourceUrl": "https://doi.org/10.14309/ajg.0000000000001259",
      "verified": true
    },
    {
      "title": "Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial",
      "journal": "The Lancet Infectious Diseases",
      "year": 2013,
      "citationCount": 328,
      "doi": "10.1016/s1473-3099(13)70033-1",
      "sourceUrl": "https://doi.org/10.1016/s1473-3099(13)70033-1",
      "verified": true
    },
    {
      "title": "Review article: herbal and dietary supplement hepatotoxicity",
      "journal": "Alimentary Pharmacology & Therapeutics",
      "year": 2012,
      "citationCount": 316,
      "doi": "10.1111/apt.12109",
      "sourceUrl": "https://doi.org/10.1111/apt.12109",
      "verified": true
    },
    {
      "title": "Acetaminophen-related Hepatotoxicity",
      "journal": "Clinics in Liver Disease",
      "year": 2013,
      "citationCount": 307,
      "doi": "10.1016/j.cld.2013.07.005",
      "sourceUrl": "https://doi.org/10.1016/j.cld.2013.07.005",
      "verified": true
    },
    {
      "title": "Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1",
      "journal": "Gastroenterology",
      "year": 2016,
      "citationCount": 302,
      "doi": "10.1053/j.gastro.2016.02.026",
      "sourceUrl": "https://doi.org/10.1053/j.gastro.2016.02.026",
      "verified": true
    },
    {
      "title": "Racial differences in responses to therapy with interferon in chronic hepatitis C",
      "journal": "Hepatology",
      "year": 1999,
      "citationCount": 297,
      "doi": "10.1002/hep.510300319",
      "sourceUrl": "https://doi.org/10.1002/hep.510300319",
      "verified": true
    },
    {
      "title": "Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease",
      "journal": "Gastroenterology",
      "year": 2016,
      "citationCount": 277,
      "doi": "10.1053/j.gastro.2016.02.078",
      "sourceUrl": "https://doi.org/10.1053/j.gastro.2016.02.078",
      "verified": true
    },
    {
      "title": "Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C",
      "journal": "Gastroenterology",
      "year": 1995,
      "citationCount": 260,
      "doi": "10.1016/0016-5085(95)90209-0",
      "sourceUrl": "https://doi.org/10.1016/0016-5085(95)90209-0",
      "verified": true
    },
    {
      "title": "NACSELD acute‐on‐chronic liver failure (NACSELD‐ACLF) score predicts 30‐day survival in hospitalized patients with cirrhosis",
      "journal": "Hepatology",
      "year": 2018,
      "citationCount": 260,
      "doi": "10.1002/hep.29773",
      "sourceUrl": "https://doi.org/10.1002/hep.29773",
      "verified": true
    },
    {
      "title": "Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1",
      "journal": "Hepatology",
      "year": 2004,
      "citationCount": 260,
      "doi": "10.1002/hep.20212",
      "sourceUrl": "https://doi.org/10.1002/hep.20212",
      "verified": true
    },
    {
      "title": "Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial",
      "journal": "The Lancet",
      "year": 2015,
      "citationCount": 257,
      "doi": "10.1016/s0140-6736(15)60159-3",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(15)60159-3",
      "verified": true
    },
    {
      "title": "Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis",
      "journal": "Hepatology",
      "year": 2015,
      "citationCount": 255,
      "doi": "10.1002/hep.27826",
      "sourceUrl": "https://doi.org/10.1002/hep.27826",
      "verified": true
    },
    {
      "title": "New Consensus Definition of Acute Kidney Injury Accurately Predicts 30-Day Mortality in Patients With Cirrhosis and Infection",
      "journal": "Gastroenterology",
      "year": 2013,
      "citationCount": 252,
      "doi": "10.1053/j.gastro.2013.08.051",
      "sourceUrl": "https://doi.org/10.1053/j.gastro.2013.08.051",
      "verified": true
    },
    {
      "title": "Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels",
      "journal": "Gastroenterology",
      "year": 2004,
      "citationCount": 244,
      "doi": "10.1053/j.gastro.2004.09.050",
      "sourceUrl": "https://doi.org/10.1053/j.gastro.2004.09.050",
      "verified": true
    },
    {
      "title": "Hepatic Decompensation in Antiretroviral-Treated Patients Co-Infected With HIV and Hepatitis C Virus Compared With Hepatitis C Virus–Monoinfected Patients",
      "journal": "Annals of Internal Medicine",
      "year": 2014,
      "citationCount": 244,
      "doi": "10.7326/m13-1829",
      "sourceUrl": "https://doi.org/10.7326/m13-1829",
      "verified": true
    }
  ],
  "awards": [],
  "timeline": [],
  "openalexId": "https://openalex.org/A5039066540",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/b/b7/Etela_Rajendera.jpg/330px-Etela_Rajendera.jpg"
}